E
Nuvectis Pharma, Inc. NVCT
$9.44 -$0.05-0.53%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 5.65% 29.38% 22.42% -3.01% 1.11%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -6.48% 2.29% 32.84% -7.56% 153.11%
Change in Net Operating Assets 70.23% -60.77% -78.37% 30.38% -42.48%
Cash from Operations 35.97% 25.89% 26.03% 8.77% -9.50%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 338.73% 32.19% -87.43% 590.74% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -875.00% 88.56% 89.48% 66.00% 112.21%
Cash from Financing 317.56% 107.25% -87.35% 1,763.49% 800.00%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 146.51% 62.73% -114.76% 107.47% 19.58%
Weiss Ratings